BRM5014 Therapeutic approaches and biotechnology
Faculty of Medicine, Nursing and Health Sciences
BRM5014 Therapeutic approaches and biotechnology is a level 5, 6-credit-point, postgraduate unit from the Faculty of Medicine, Nursing and Health Sciences, offered in 2020 in Semester 1 at Clayton. It has no prerequisites.
- Credit points
- 6
- Offered in 2020
- Semester 1
- Clayton
This is the 2020 handbook entry. See the 2027 entry.
Reviews
No reviews yetNo reviews yet. Be the first to review BRM5014.
Requisites
Before BRM5014
No prerequisites or corequisites besides the enrolment rules below.
After BRM5014
No unit lists BRM5014 as a prerequisite in the 2020 handbook.
Enrolment rules
Overview
This unit covers the fundamentals and principles of modern biotechnology-based therapeutic approaches for treating and managing diseases.
Students will learn about the cellular and molecular basis of drug actions that underpin new drug development.
The general principles of the pathway for developing a new drug or biotechnological device for therapeutic clinical use will be outlined.
Students will be introduced to specific novel regenerative medicine approaches based on biotechnological developments, including therapeutic stem cells, immunotherapy, tissue engineering, organ transplantation, and artificial organs.
In addition, students will gain research methodology and skills through a range of practical activities, including designing experiments to test for pharmacological properties and using statistical approaches to assess therapeutic efficacy of drugs.
Offerings in 2020
| Teaching period | Campus | Mode |
|---|---|---|
| First semester | Clayton | On campus |
Learning outcomes
When you finish this unit, you should be able to:
- 1
Apply basic principles of pharmacology to the development of new pharmacotherapeutics
- 2
Examine the pharmacological properties of drugs and select appropriate statistical approaches to assess therapeutic efficacy
- 3
Explain the rationale of current regenerative medicine approaches, including cell and gene therapy, immunotherapy, and bone marrow transplantation.
- 4
Critically appraise the application and effectiveness of current regenerative medicine approaches in the treatment of specific human diseases
- 5
Integrate knowledge of the drug and device development and approval process, to plan a proposal for a new therapeutic product
Workload and teaching
6 hours of directed learning including 4 contact hours per week, 2 hours of lectures and 2 hours of workshop/ tutorial/ practical per week and 6 hours of self-directed learning including private study per week.
Contacts
- Unit Coordinators
- Dr Chau Khuong
- Chief Examiners
- Professor Graham Lieschke
Common questions
What are the prerequisites for BRM5014?
BRM5014 has no prerequisites, but enrolment rules apply.
When is BRM5014 offered?
In 2020, BRM5014 runs in Semester 1 at Clayton.